These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 20723338)

  • 1. Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease.
    Tinè M; Balestro E; Carpi S; Neri T; Biondini D; Conti M; Casara A; Bernardinello N; Cocconcelli E; Turato G; Baraldo S; Celi A; Spagnolo P; Cosio MG; Saetta M; Bazzan E
    Front Immunol; 2024; 15():1320077. PubMed ID: 38533493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relating NF-κB regulation to MPN pathogenesis.
    Sullivan JY; Fleischman AG
    Blood; 2024 Jun; 143(23):2345-2347. PubMed ID: 38842861
    [No Abstract]   [Full Text] [Related]  

  • 3. Bypassing the cytokine sink: IL-2-independent IL-2 receptor signaling.
    Luetkens T
    Mol Ther; 2023 Aug; 31(8):2304-2306. PubMed ID: 37482059
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
    Zhang MY; Fung TK; Chen FY; Chim CS
    J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of single nucleotide polymorphism of SOCS gene in typical myeloproliferative neoplasms].
    Qin W; Chen T; Yang JH; Zhang Y; Xiao R; Lu JT; Wang T; Zhou M; He JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1507-12. PubMed ID: 24370038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS3 in liver regeneration and hepatocarcinoma.
    Elliott J
    Mol Interv; 2008 Feb; 8(1):19-21, 2. PubMed ID: 18332480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
    Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advances on relationship between suppressor of cytokine signaling 3 and myeloproliferative neoplasms].
    Qin W; Fu JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1101-4. PubMed ID: 20723338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins.
    Linossi EM; Nicholson SE
    Immunol Rev; 2015 Jul; 266(1):123-33. PubMed ID: 26085211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Advances on Suppressor of Cytokine Signaling 3 (SOCS3) in Animal Carbohydrate and Lipid Metabolism Processes.
    Liu W; Wang X
    Pak J Biol Sci; 2022 Nov; 25(12):1100-1108. PubMed ID: 36978278
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.